Health & Science

Dr. Mari Mitrani of OrganiCell on Stem Cell Research, Exosomes, and Regenerative Medicine

Dr. Mari Mitrani, Chief Science Officer of OrganiCell, explains what stem cells actually are, why perinatal-source stem cells and exosomes represent the cutting edge of regenerative medicine, and why none of it requires embryonic or animal testing.

SoFlo Vegans Podcast

Episode 22 · Dec 19, 2019 · 46 min

Open on the show page Every episode

Topics Covered

Dr. Mitrani's upbringing in Ecuador by two physician parents who practiced whole-food, plant-based medicine decades before it was mainstream
What a stem cell is: an undifferentiated 'master cell' capable of becoming any specialized tissue in the body
The early years of autologous (patient's-own) stem cell therapy, including bone marrow and blood-derived collection methods
Why embryonic stem cells are controversial and carry teratoma risk, and how perinatal-source stem cells from planned, fully-screened C-section donations avoid that issue entirely
Exosomes explained: the newly understood cell-to-cell communication vesicles now used for both diagnosis and treatment
Current clinical research into osteoarthritis of the knee, cardiology, and pulmonology applications
Why no animal testing is used in her company's autologous and perinatal stem cell research

About the Guest

Dr. Mari Mitrani is Chief Science Officer of OrganiCell, a regenerative medicine company researching stem cell and exosome therapies for orthopedic, cardiac, and pulmonary conditions. She was raised in Ecuador in a family of physicians who practiced whole-food, plant-based and natural medicine, and has spent over a decade at the forefront of stem cell and exosome research.